抗虹吸装置对特发性正常压力脑积水术后结局的影响
本研究回顾性分析140例疑似特发性正常压力脑积水患者,其中99例接受脑室腹腔分流术,比较带或不带集成抗虹吸装置(ASD)的分流阀在临床获益和并发症上的差异。结果显示两组临床反应率(94% vs. 92%,P=0.74)和过度引流并发症(22% vs. 22%,P=0.96)均无显著差异,ASD未显著改善术后结局。
要点
- ASD组与标准分流阀组临床反应率和最终分流设置时间无显著差异。
- ASD组过度引流并发症发生率与对照组相当(22% vs. 22%,P=0.96)。
- ASD未显著延长无过度引流时间间隔,无特殊原因信号。
核心结论
- 集成ASD的脑室腹腔分流术在临床获益、最终分流设置时间、过度引流及非过度引流并发症方面与不带ASD的分流术相似。
研究设计与样本
- 回顾性队列研究,纳入140例因疑似特发性正常压力脑积水行腰大池引流试验的患者,其中99例接受脑室腹腔分流术。
- 99例中49例使用集成ASD的分流阀,50例使用标准可调压阀(开启压力215 mm水柱)。
- 中位随访时间分别为14.6个月和16.3个月。
主要发现
- 临床反应率ASD组94% vs. 对照组92%(P=0.74),最终分流设置时间无显著差异(P=0.83)。
- 过度引流并发症总体发生率ASD组22% vs. 对照组22%(P=0.96)。
- 硬膜下血肿发生率6% vs. 12%(P=0.33),硬膜下水瘤8% vs. 4%(P=0.43),过度引流头痛8% vs. 6%(P=0.70)。
- 因过度引流手术干预2% vs. 8%(P=0.22),跌倒伴急诊就诊2% vs. 10%(P=0.12)。
- ASD引入未显著增加无过度引流时间间隔(无特殊原因信号,<3个标准差)。
临床怎么用
- 对于特发性正常压力脑积水患者,选择集成ASD的分流阀并未显示出比标准可调压阀更优的临床获益或更低的并发症风险。
- 临床决策时应综合考虑患者个体情况,不应仅依据是否使用ASD来预期术后结局的差异。
局限性
- 本研究为回顾性设计,可能存在选择偏倚和信息偏倚。
- 样本量有限(99例分流患者),可能不足以检测出微小差异。
- 随访时间较短(中位14.6-16.3个月),长期结局未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Ventriculoperitoneal shunts (VPS) integrated with purported anti-siphon devices (ASDs) were introduced with the goal of reducing the sequelae of overdrainage. We aim to compare the clinical benefit and complications of patients with idiopathic normal pressure hydrocephalus who underwent VPS surgery with or without an integrated ASD. METHODS: We retrospectively reviewed 140 patients who underwent a lumbar drain trial for possible idiopathic normal pressure hydrocephalus, 99 of whom underwent VPS surgery. Overdrainage complications included subdural hematoma, subdural hygroma, overdrainage headaches, and surgical interventions for overdrainage. Nonoverdrainage complications included falls with emergency department visit. RESULTS: Of 99 patients who received shunts, 49 had shunts with integrated ASDs and 50 had standard shunts with programmable valves (opening pressure, 215 mm of water; median follow-up, 14.6 vs. 16.3 months). Clinical response (94% vs. 92%; P = 0.74) and time to final shunt setting (P = 0.83) were similar between cohorts. ASDs were associated with no significant change in overdrainage complications (22% vs. 22%, P = 0.96). Patients with ASDs had no significant differences in rates of individual complications (subdural hematoma: 6% vs. 12%, P = 0.33; subdural hygroma: 8% vs. 4%, P = 0.43; overdrainage headache: 8% vs. 6%, P = 0.70; surgical interventions: 2% vs. 8%, P = 0.22; falls: 2% vs. 10%, P = 0.12). Introduction of ASDs was not associated with a significant increase in time interval free of overdrainage (no special cause signal, <3 standard deviations). CONCLUSIONS: VPSs integrated with ASDs are associated with similar clinical benefit, time to final shunt setting, overdrainage complications, and nonoverdrainage complications compared to shunts without ASDs.
引用
- Hafizka Y, Shah S, Salcedo-Sifuentes J, et al. Effect of Anti-Siphon Devices on Postoperative Outcomes in Idiopathic Normal Pressure Hydrocephalus. World Neurosurg. 2026. PMID: 41941959. doi:10.1016/j.wneu.2026.124975
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。